SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-21-007158
Filing Date
2021-03-25
Accepted
2021-03-25 16:10:48
Documents
103
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nby20201231_10k.htm 10-K 1819513
2 EXHIBIT 4.1 ex_236243.htm EX-4.1 16125
3 EXHIBIT 23 ex_233816.htm EX-23 2247
4 EXHIBIT 31.1 ex_233817.htm EX-31.1 7794
5 EXHIBIT 31.2 ex_233818.htm EX-31.2 7964
6 EXHIBIT 32.1 ex_233819.htm EX-32.1 3799
7 EXHIBIT 32.2 ex_233820.htm EX-32.2 3663
  Complete submission text file 0001437749-21-007158.txt   10567789

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nby-20201231.xml EX-101.INS 2321607
9 XBRL TAXONOMY EXTENSION SCHEMA nby-20201231.xsd EX-101.SCH 119026
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20201231_cal.xml EX-101.CAL 78659
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20201231_def.xml EX-101.DEF 731280
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20201231_lab.xml EX-101.LAB 617538
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20201231_pre.xml EX-101.PRE 773443
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33678 | Film No.: 21772467
SIC: 2834 Pharmaceutical Preparations